"10.1371_journal.pone.0021868","plos one","2011-07-05T00:00:00Z","Sushmita Sinha; Lisa M Miller; Sandhya Subramanian; Gregory G Burrows; Arthur A Vandenbark; Halina Offner","Neuroimmunology Research, Veterans Affairs Medical Center, Portland, Oregon, United States of America; Department of Neurology, Oregon Health & Science University, Portland, Oregon, United States of America; Department of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, Oregon, United States of America; Research Service, Department of Veterans Affairs Medical Center, Portland, Oregon, United States of America; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, United States of America; Department of Anesthesiology and Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, United States of America","Conceived and designed the experiments: S. Sinha HO. Performed the experiments: S. Sinha LM S. Subramanian. Analyzed the data: S. Sinha. Contributed reagents/materials/analysis tools: GGB AAV. Wrote the paper: S. Sinha HO AAV.","Drs. Burrows, Vandenbark and Offner and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VAMC Conflict of Interest in Research Committees. Dr. Offner and Dr. Vandenbark have stock options in Virogenomics/Artielle Immuno Therapeutics, Inc. that has licensed the RTL technology. Dr. Offner has submitted a patent application on “RTL551 treatment of EAE reduces CD226 & T-bet+ CD4 T-cells in periphery & prevents infiltration of T-bet+ & IL17 & IFNγ producing T cells into the CNS,” that might be licensed to Artielle Immuno Therapeutics, Inc. as a new use for RTLs. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","07","Sushmita Sinha","SS",6,TRUE,1,1,1,1,TRUE,TRUE,TRUE,2,"2;6",TRUE
